VAXART, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.705 USD | -3.64% |
|
-3.28% | +23.08% |
| Mar. 14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VAXART, INC. | Bio Therapeutic Drugs | -3.64% | -3.28% | +23.08% | -32.21% | -8.44% | 125M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VXRT Stock
- Charts Vaxart, Inc.
- Comparison Chart